Authors


Tina Zerilli, PharmD

Latest:

Zuranolone Offers An Innovative Treatment for Postpartum Depression

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.


Ronald E. Aubert, PhD, MSPH

Latest:

Impact of Specialty Pharmacy on Treatment Costs for Rheumatoid Arthritis

For patients who use biologic treatments for rheumatoid arthritis, specialty pharmacy care yields higher medication adherence and lower medical costs than retail pharmacy care.


Robert Abouassaly, MD

Latest:

Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

Study investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.


John R. Horn, PharmD, FCCP

Latest:

Estrogens and Lamotrigine: New Developments

Practitioners have known for almost 2 decades that oral contraceptives consistently and substantially reduce the serum concentrations of lamotrigine and may reduce seizure control.



Timothy O'Shea

Latest:

Treatments for Tardive Dyskinesia: What Pharmacists Should Know

There are two recently approved medications for this condition.


Julia K. Nguyen, PharmD

Latest:

Effect of Dispensing Supply on Pravastatin Refill Adherence

In uninsured, indigent, and low-income patients with hyperlipidemia, optimum pravastatin refill adherence was observed with a 90-day dispensing supply.


Dorinda Martin, RPh, PharmD, FACA, FASAP

Latest:

Cost of Dispensing Specialty Drugs May Be More Than You Think

Smaller entrepreneurial pharmacy owners are proactively pursuing the dispensing of specialty medications.


Kristin McMahon, PharmD, MBA

Latest:

Complete Immunization Services Start With Gathering Patient Information

Pharmacy team members have the amazing opportunity to help ensure that people and communities are protected with proper immunizations during influenza (flu) season and beyond, but they may struggle with identifying patients who may benefit because it can be difficult to gather information from patients.


Kristin Coppock, MA, Managing Editor

Latest:

HOPA 2021: New Therapies on the Horizon for Advanced NSCLC

A session at the Hematology/Oncology Pharmacy Association Virtual Annual Conference provided an overview of how treatment options are changing with potential new therapies in development for patients with non-small cell lung cancer.


Jennifer E. MacDonald, PharmD

Latest:

Understanding the Evolving Landscape of Malignant Melanoma

This Continuing Education activity is supported by an educational grant from Merck Sharpe & Dohme Corp.



Christine Kubus, 2016 PharmD Candidate

Latest:

Could Zinc Supplements Help Prevent Febrile Seizures?

Some evidence suggests that a febrile seizure occurs when the child has low serum zinc levels.


Kristina Barakov, PharmD Candidate

Latest:

New Insulin Products and Best Practices

Even with many new developments over the past century, the coordinated use of blood glucose monitors, diabetes medications, and insulin to manage the disease may be too intricate for some patients.


Erika Ohashi, BA

Latest:

Cost Impact of Switching From Metoprolol to Nebivolol for Hypertension

A large single-payer administrative claims database was used to assess the economic impact of switching from metoprolol to nebivolol for the treatment of hypertension.


Maureen Miller, MPH, RN

Latest:

Medicare Plans Face New Oversight and Scrutiny From Audit Changes

The 2015 Medicare Part D audit protocols add a layer of complexity to Part D plans and increase their probability of receiving mandatory corrective actions.


Jay Lin, PhD, MBA

Latest:

Modeled Cost Differences Associated With Use of Levonorgestrel Intrauterine Devices

This analytic model assessed the per-woman cost differences between the use of 2 levonorgestrel-releasing intrauterine devices, from a US payer perspective.


Lyndsay Wormuth, PharmD, BCACP

Latest:

Latent Tuberculosis After the Use of Etanercept

TNF-alpha inhibitors are used to treat a number of inflammatory conditions.


Leann Kwak, PharmD Candidate

Latest:

Bringing Students and Faculty Together Over Tea

Although pharmacy schools are known for their advancements in pharmacy education, scientific discovery, and patient care, they still face an unspoken and universal truth shared among institutions of higher learning: students sometimes feel lost and unsure of themselves, and as if they have no one to whom they can turn.


Greg Lenhart, MS

Latest:

Impact of Patient Cost Sharing on Multiple Sclerosis Treatment

This study evaluates the impact of patient cost sharing on the probability of receiving disease-modifying therapies and treatment compliance among patients with multiple sclerosis.


Ryan W. Stevens, PharmD, BCPS

Latest:

Antimicrobial Stewardship Targets in Community-Acquired Pneumonia

Antimicrobial stewardship programs (ASPs) are often tasked with addressing a wide scope of antimicrobial misuse with limited resources.


Con Lane, Director, Franchise Development, Medicine Shoppe International, Inc.

Latest:

How One Oregon Pharmacy Owner Saw a Local Need for a Second Pharmacy and Filled It

Learn how Medicine Shoppe International, Inc. helped one seasoned pharmacy owner open a “backfill pharmacy” in the spot where another had recently closed.


Tyler Page, PharmD

Latest:

Variations and Nuances in Colorectal Cancer Drug Dosing

Specialty pharmacists need to fully understand capecitabine’s place in colorectal cancer treatment to ensure that it is safely and effectively utilized.


Tricia Gangoo-Dookhan, PharmD, BSPharm

Latest:

Changing the Game: Pharmacy Students' Perspective on Naloxone OTC Approval

To eliminate the existing stigma in the community, addiction must be recognized as a treatable condition rather than an immoral act.


Annabelle Dorion, PharmD Candidate 2017

Latest:

Rotating Globally

One of the main reasons I chose to attend Howard University College of Pharmacy was its International Experiential Rotation program.




Lillian Smith, PharmD, MBA, CPh

Latest:

Afrezza

Nearly 30% of patients with diabetes have reported that injectable insulin was the most difficult part of their care regimen.


Mina Baghzouz, PharmD

Latest:

Late-Stage Pipeline Review for Multiple Sclerosis Treatments

Current stage 3 trials for multiple sclerosis medications may address several unmet needs in the patient population.


Kirstin Schmidt, RN

Latest:

Value-Based Care in Specialty Populations: High-Quality Clinical Management of Home Infusion Hemophilia Patients Reduces Costs, Maintains Outcomes

High-quality clinical management of home infusion hemophilia patients reduces costs and maintains outcomes.